2024 Stock Picks
- Thread starter vanzandt
- Start date
Update... As much as I like this stock long term, I don't trust it near term after taking all things "Friday" into consideration.
Wait for lower. It could retest $54.
It is getting hammered. $8.80
Ugly report. Don't touch it.
Perfect report.Ok I'll look.
I just logged on to give out what I think will be a good earnings play as well as a long term hold.
OSUR ---> Orasure Technologies. $4.31
It's a medical device and testing company.
https://orasure.com/
I've followed the story and they are on the upswing. It's very well run. They are going to beat and raise, I'm pretty sure.
Here's the crown jewel :
We ended the quarter with zero debt and total cash, cash equivalents and short-term investments of $290 million, which is $65 million increase from the prior quarter. The increase in our cash balance during the fourth quarter was primarily driven by $41 million of operating cash flow.
There is only 74M shares outstanding. That is $3.91/share. You're buying this company for $0.40/ share.
Here's something I learned lol... the incidence of Syphilis is exploding, both in the US and worldwide (so you young bucks best be careful).
https://www.nytimes.com/2024/07/25/opinion/syphilis-disease-rates-rising.html
These guys just inked a deal with a NJ company, leveraging OSUR's worldwide distribution network to distribute this NJ company's rapid Syphilis test kits. They say it will bump revenue by 2% in 2024. Talk about good timing.
They're also in bed with the U.S. Government for Covid testing, and they just got a bonus check for completing the expansion of a production facility early. The way I read it, the facility can be utilized to make testing kits for whatever may come down the road. They also do E-Bola stuff. And rapid drug testing kits. Folks interested can read about their products in the above link. I don't need to cover all that.
I like the story and I like the management's cost-cutting initiatives to improve GAAP margins. I think they sand-bagged guidance, and I think they are going to beat/beat/raise. Not by much, because they're very prudent... but the story's there.
It's my top pick for the week. It's a good one considering this market atm. This company is not affected by the Fed, Iran/Israel, etc.
As always... do your own dd.
This is a good company folks. Up 6.25% in the ah's.... but no volume on that.
I was a little disappointed with the forward guidance, albeit it came in at the top of the range.
I can tell she (the ceo) plays things very conservatively. Hey I'm not a big fan of stocks under $5, but I told several friends today to buy stock in this company. I'll tell you what... it is going up. Just give it some time. IRA it.
Manners are a good thing. She's sharp. This company is a steal down here.
Gotta love a BSME from ND. I wonder if Purdue rejected her.
« Back
Carrie Eglinton Manner
President & Chief Executive Officer
Carrie Eglinton Manner was named President and Chief Executive Officer of OraSure Technologies in June 2022 and brings more than 25 years of healthcare leadership and transformation expertise to the Company. Prior to joining OraSure, Ms. Manner was Senior Vice President, Advanced & General Diagnostics Clinical Solutions, at Quest Diagnostics. In that role, she was responsible for bringing innovative diagnostic solutions to market in the areas of women’s health, neurology, oncology, cardiovascular, metabolic, endocrinology, infectious disease, and immunology testing services, as well as drug monitoring and toxicology. She also led Quest’s pharmaceutical services, AmeriPath/Dermpath, and international businesses, as well as their molecular genetics team in pioneering next-generation sequencing innovation. Prior to Quest Diagnostics, Ms. Eglinton Manner served for 20 years in a variety of leadership roles at GE Healthcare, a division of General Electric (GE). A champion for inclusion and diversity, Ms. Eglinton Manner was co-chair for Quest’s African American Employee Business Network and GE’s Women’s Network. Ms. Manner received a B.S. degree in mechanical engineering from University of Notre Dame.
___________________________________________________
You go Carrie!
Show the WS Ivy League MBA's which degree produces results.
I doubt Boeing (despite that idiot Stoney saying 'I wanted a CEO with a little more experience'... whatever that f'ing means... I mean... he has no clue... as in clueless.)... f'd up. And the Boeing CEO only went to Iowa for his BSME. Purdue and the Irish... they wouldn't even let him in.
#1 VZ STOCK PICK---->OSUR
Company Overview
Headquartered in Bethlehem, PA, OraSure is a leader in the development, production, and distribution of point-of-care diagnostic and collection devices, and other technologies designed to detect or diagnose critical medical conditions. Our innovative products include rapid tests for COVID-19, HIV, HCV, syphilis, Ebola, and substance use. Bethlehem is home to our largest employee base and our state-of-the-art manufacturing facility.
OraSure is also the parent company of DNA Genotek, Inc., in Ottawa, Canada, (In this particular case, we wont hold that against them. It is the Capitol) where our team develops world-class sample collection solutions. Our portfolio of sample collection solutions includes innovation to stabilize multiple types of DNA and RNA samples for years at ambient temperature. The self-collection products for saliva, gut, oral, fecal, vaginal, and skin samples are designed to maximize reach and access to testing, enabling breakthroughs in genomics research, diagnostics laboratories, the pharmaceutical industry, animal genomics, and personal genomics. We also have a collection device for first-void urine samples that is used to detect certain urological cancers and sexually transmitted infections, currently available in some global geographies and for research use.
Headquartered in Bethlehem, PA, OraSure is a leader in the development, production, and distribution of point-of-care diagnostic and collection devices, and other technologies designed to detect or diagnose critical medical conditions. Our innovative products include rapid tests for COVID-19, HIV, HCV, syphilis, Ebola, and substance use. Bethlehem is home to our largest employee base and our state-of-the-art manufacturing facility.
OraSure is also the parent company of DNA Genotek, Inc., in Ottawa, Canada, (In this particular case, we wont hold that against them. It is the Capitol) where our team develops world-class sample collection solutions. Our portfolio of sample collection solutions includes innovation to stabilize multiple types of DNA and RNA samples for years at ambient temperature. The self-collection products for saliva, gut, oral, fecal, vaginal, and skin samples are designed to maximize reach and access to testing, enabling breakthroughs in genomics research, diagnostics laboratories, the pharmaceutical industry, animal genomics, and personal genomics. We also have a collection device for first-void urine samples that is used to detect certain urological cancers and sexually transmitted infections, currently available in some global geographies and for research use.
Carrie Eglinton Manner
President & Chief Executive Officer
Ms. Eglinton Manner was co-chair for Quest’s African American Employee Business Network and GE’s Women’s Network.
but she is white
Well lets all hope higher IQ's that don't judge folks by color or gender... prevail. She could have zebra stripes for all I f'ing care.
This country has lost its f'ing mind.
